| Patents for C07C 311 - Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups (17,647) |
|---|
| 04/30/2003 | CN1414849A Carboxylic acid amides, medicaments containing these compounds and the use and preparation thereof |
| 04/29/2003 | USRE38103 Preferential, nontoxic oxidoreductase inhibitors such as 5-Methanesulfonamido-6-(2,4-difluorophenylthio)-1-indanone administered for prophylaxis of gastrointestinal disorders |
| 04/29/2003 | US6555714 P-hydrophenylpyruvate dioxygenases (HPPD) from plants is incubated with test substrate and enzymatic activity of enzyme is determined in comparison with activity of uninhibited enzyme |
| 04/29/2003 | US6555584 Acylsulfonamide derivative |
| 04/29/2003 | US6555570 Growth hormone secretagogous with improved bioavailability |
| 04/29/2003 | US6555510 Bis(perfluoroalkanesulfonyl)imides and their salts as surfactants/additives for applications having extreme environments and methods therefor |
| 04/29/2003 | CA2035340C Hydroxycarbonyl derivatives and process for making the same |
| 04/24/2003 | WO2003033459A1 Method for producing arylsuphonic acid isocyanates |
| 04/24/2003 | WO2003032999A1 Alkyne matrix metalloproteinase inhibitors |
| 04/24/2003 | WO2003032972A1 5’-carbamoyl-1,1-biphenyl-4-carboxamide derivatives and their use as p38 kinase inhibitors |
| 04/24/2003 | WO2003032970A1 5'-carbamoyl-2'-methyl-1,1'-biphenyl-4-carboxamide derivatives and their use as p38 kinase inhibitors |
| 04/24/2003 | WO2002062769A3 Preparation and purification of antiviral disulfonic acid disodium salt |
| 04/24/2003 | US20030078434 An aromatic sulfonamide compound for treating glomerulonephritis and diabetic nephropathy, having a superior antiproteinuric effect and superior inhibitory activity for type IV collagenase |
| 04/24/2003 | US20030078302 As carriers for delivering active agents such as peptides, drugs by administration, such as oral, subcutaneous, sublingual, and intranasal administration |
| 04/24/2003 | US20030078261 Prostaglandin agonists |
| 04/24/2003 | US20030078250 Diphenyl urea compounds for treating a chemokine mediated disease; interleukin-8 (il-8) |
| 04/24/2003 | CA2462442A1 Alkyne matrix metalloproteinase inhibitors |
| 04/23/2003 | EP1304322A2 Carboxylic acid compound and use thereof |
| 04/23/2003 | EP1303503A2 Aniline derivatives |
| 04/23/2003 | EP1303483A1 Novel thiourea derivatives and the pharmaceutical compositions containing the same |
| 04/23/2003 | EP1303482A2 N-substituted-1-amino-1,1-dialkylcarboxylic acid derivatives |
| 04/23/2003 | EP0993442B1 Hydrazine derivatives |
| 04/23/2003 | CN1413210A Non-peptidyl inhibitors of VLA-4 dependent cell binding useful in treating inflammatory, autoimmune, and respiratory diseases |
| 04/23/2003 | CN1413187A Aromatic diamide derivatives, chemicals for agricultural or horticultural use and usage thereof |
| 04/23/2003 | CN1413185A Substitued 1 and 2 naphthol mannich bases |
| 04/23/2003 | CN1413181A Novel hydronaphtalene compounds prepared by phodium catalyzed ring opening reaction in presence of phosphine ligand |
| 04/22/2003 | US6552225 Such as n-(2,3-dichloro-4-(methylaminosulphonyl)phenyl)-3,3,3-trifluoro-2-hydroxy-2 -methylpropanamide; diabetes, obesity, lactic acidaemia |
| 04/22/2003 | US6552216 Molecular model for VLA-4 inhibitors |
| 04/22/2003 | US6552086 For therapy of psychiatric and neurological disorders |
| 04/22/2003 | US6552082 Solubility makes it possible to manufacture a solution of higher concentration of the compound and high-dosage drug product |
| 04/22/2003 | US6552079 Integrin antagonists |
| 04/22/2003 | US6552048 Sulfonylcarboxamide derivatives, process for their preparation and their use as pharmaceuticals |
| 04/22/2003 | US6552038 Anticoagulant agents |
| 04/22/2003 | US6551999 Angiogenesis inhibitor |
| 04/17/2003 | WO2003031404A2 Processes for the preparation of substituted isoxazoles and 2-isoxazolines |
| 04/17/2003 | WO2003031397A1 Acylsulfonamides as inhibitors of steroid sulfatase |
| 04/17/2003 | US20030073862 Antidiabetic agents, anticancer agents, anticholesterol agents |
| 04/17/2003 | US20030073846 Aminoalcohol derivatives |
| 04/17/2003 | US20030073845 Sulfonyl aryl hydroxamates and their use as matrix metalloprotease inhibitors |
| 04/17/2003 | US20030073833 Antiinflammatory agents; anticoagulants |
| 04/17/2003 | US20030073712 Antiinflamamtory agents; antiischemic agents |
| 04/17/2003 | US20030073684 Respiratory system disorders; cardiovascular disorders; hemorrhage therapy |
| 04/17/2003 | US20030073641 Novel N-(arylsulphonyl) amino acid derivatives, process for their preparation and pharmaceutical compositions containing them |
| 04/17/2003 | US20030073202 Polymerase transcription accelerator for use tool in determining nucleotide sequences |
| 04/17/2003 | US20030070241 Substituted 2-aminoalkyl-1,4-Diaminobenzene compounds and oxidation dye precursor compositions containing same |
| 04/17/2003 | CA2458453A1 Acylsulfonamides as inhibitors of steroid sulfatase |
| 04/16/2003 | EP1302468A1 Processes and intermediates for manufacturing retroviral protease inhibiting compounds |
| 04/16/2003 | EP1302461A1 Tnf-alpha production inhibitors |
| 04/16/2003 | EP1301474A2 Tyrosine derivatives as phosphatase inhibitors |
| 04/16/2003 | EP1301467A2 9-substituted minocycline compounds |
| 04/16/2003 | EP1301466A2 7-substituted tetracycline compounds |
| 04/16/2003 | EP1301464A1 Biphenylcarboxylic acid amides, production thereof and use thereof as medicaments |
| 04/16/2003 | EP1301275A1 Composition and compound based on metal and acid salt(s) having a sulphonyl group borne by a perhalogenated carbon and their use as lewis acid |
| 04/16/2003 | EP1094812A4 Angiogenesis inhibitors |
| 04/16/2003 | CN1411438A Method for preparing fluorosulfonyl imide monomer |
| 04/16/2003 | CN1411437A Process for preparation of diphenyl ether compounds |
| 04/16/2003 | CN1105558C 2,2-dichloroalkane carboxylic acids, process for preparing same, medicament containing same and use for treating insulin resistance |
| 04/15/2003 | US6548706 Directly from a halomethyl alcohol protected amine derivative and an amine or alkyl carbamate substituted halomethyl alcohol without having to isolate the toxic boc-epoxide; high yield of pure enantiomorph |
| 04/15/2003 | US6548567 Ionic compounds with delocalized anionic charge, and their use as ion conducting components or as catalysts |
| 04/15/2003 | US6548548 Cardiovascular disorders; anticholesterol agents |
| 04/15/2003 | US6548547 Sulfonylamino carboxylic acid N-arylamides as guanylate cyclase activators |
| 04/15/2003 | US6548546 HIV integrase inhibitors |
| 04/10/2003 | WO2003029199A1 Benzene derivatives, process for preparing the same and use thereof |
| 04/10/2003 | WO2003029169A2 Hydroxypropylamines |
| 04/10/2003 | WO2003028641A2 Mch receptor antagonists |
| 04/10/2003 | US20030069312 Nitromethyl ketones, process for preparing them and compositions containing them |
| 04/10/2003 | US20030069287 Process for preparing prodrugs of benzenesulfonamide-containing cox-2 inhibitors |
| 04/10/2003 | US20030069222 Used as anti-viral agents against the HIV-1 and HIV-2 viruses. |
| 04/10/2003 | US20030066988 Electroconductivity coloring |
| 04/10/2003 | CA2462851A1 Hydroxypropylamines |
| 04/10/2003 | CA2460594A1 Mch receptor antagonists |
| 04/09/2003 | EP1300142A1 Hypoglycemics |
| 04/09/2003 | EP1299354A2 Factor viia inhibitory (thio)urea derivatives, their preparation and their use |
| 04/09/2003 | EP1299352A2 Compounds to treat alzheimer's disease |
| 04/09/2003 | EP1299349A2 Compounds to treat alzheimer's disease |
| 04/09/2003 | CN1408706A Process for synthesizing 2,4-di-(P-n-dodecyl-oxy-phenylsulfonamido) phenol |
| 04/09/2003 | CN1105101C Beta-sultonamido hydroxamic acids as matrix metalloproteinase and TACE inhibitors |
| 04/08/2003 | US6545154 Method for the production of N-(5-amino-2-cyano-4-fluoro-phenyl)-sulphonamides and new intermediate products |
| 04/08/2003 | US6545150 Certain benzothiazine dioxide endothelin antagonists and processes for their preparation |
| 04/08/2003 | US6545055 Amidino-phenyl or -naphthyl aromatic amide derivatives |
| 04/08/2003 | US6545054 Alkenyl and alkynyl compounds as inhibitors of factor Xa |
| 04/08/2003 | US6545053 Aminoethoxyfluorene derivatives are beta-3 adrenaline receptor agonists and are useful as drugs for the treatment and prevention of diabetes, obesity, hyperlipemia, etc. |
| 04/08/2003 | US6545049 E.g., (2E, 4E, 6E)-7-(3,5-diisopropyl-2-n-heptyloxyphenyl)-3-methylocta-2,4,6-trienoic acid, esters or amides thereof |
| 04/08/2003 | US6545029 Antiosteoporotic, antirestenotic, anticarcinogenic and antiatherosclerotic |
| 04/08/2003 | US6545022 Treatment of epilepsy, faintness attacks, hypokinesia, cranial disorders, neurodegenerative disorders, depression, anxiety, panic, pain, neuropathological disorders, inflammatory diseases, and gastrointestinal disorders |
| 04/08/2003 | US6545018 Oxamic acids and derivatives as thyroid receptor ligands |
| 04/08/2003 | CA2109830C Lhrh antagonists and intermediate products |
| 04/08/2003 | CA2101423C Benzamides |
| 04/03/2003 | WO2003027075A2 Substituted pyrazolyl benzenesulfamide compounds for the treatment of inflammation |
| 04/03/2003 | WO2003027059A1 Acid amide derivatives, process for producing these, and pest control agent containing these |
| 04/03/2003 | WO2003027058A1 Sphingolipids |
| 04/03/2003 | US20030065195 Ether compounds |
| 04/03/2003 | US20030065188 Il-8 receptor antagonists |
| 04/03/2003 | US20030065187 Copper-catalyzed formation of carbon-heteroatom and carbon-carbon bonds |
| 04/03/2003 | US20030065176 Anticoagulant; cardiovascular disorders |
| 04/03/2003 | US20030065170 Antiinflammatory agents; skin disorders; rheumatic diseases |
| 04/03/2003 | US20030065031 Glucagon antagonists/inverse agonists |
| 04/03/2003 | CA2461801A1 Sphingolipids |
| 04/02/2003 | EP1296945A1 Sulfonamide derivatives |
| 04/02/2003 | EP1296944A1 Sulfonamide derivatives |